Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used